A Republican congressman told the head of the Food and Drug Administration (FDA) on Wednesday that the agency’s failure to enact regulations for CBD is one of several problems that is “disrupting public confidence” in its abilities. Rep. Andy Harris (R-MD) said during a House Appropriations subcommittee hearing that “controversies swirl around the agency.” One … Continue reading GOP Congressman Says FDA’s Lack Of CBD Regulations Is ‘Disrupting Public Confidence’ In The Agency